Home
Search 
Browse 
Download
ManualDetails of Host Protein
| Host Protein General Information (ID: PT1107) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein Name |
Succinyl-CoA synthetase beta-G chain (SCS-betaG)
|
Gene Name |
SUCLG2
|
||||||
| Host Species |
Homo sapiens
|
Uniprot Entry Name |
SUCB2_HUMAN
|
||||||
| Protein Families |
Succinate/malate CoA ligase beta subunit family
|
||||||||
| EC Number |
6.2.1.4
|
||||||||
| Subcellular Location |
Mitochondrion
|
||||||||
| External Link | |||||||||
| NCBI Gene ID | |||||||||
| Uniprot ID | |||||||||
| Ensembl ID | |||||||||
| HGNC ID | |||||||||
| Function in Host |
GTP-specific succinyl-CoA synthetase functions in the citricacid cycle (TCA), coupling the hydrolysis of succinyl-CoA to thesynthesis of GTP and thus represents the only step of substrate-levelphosphorylation in the TCA. The beta subunit provides nucleotidespecificity of the enzyme and binds the substrate succinate, while thebinding sites for coenzyme A and phosphate are found in the alphasubunit.
Click to Show/Hide
|
||||||||
| Related KEGG Pathway | |||||||||
| Citrate cycle (TCA cycle) | hsa00020 |
Pathway Map 
|
|||||||
| Propanoate metabolism | hsa00640 |
Pathway Map 
|
|||||||
| Metabolic pathways | hsa01100 |
Pathway Map 
|
|||||||
| Carbon metabolism | hsa01200 |
Pathway Map 
|
|||||||
| 3D Structure |
|
||||||||
| Function of This Protein During Virus Infection | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Virus Name | SARS-COV-2 | Protein Function | Pro-viral | [1] | |||||
| Infected Tissue | Lung | Infection Time | 7-9 Days | ||||||
| Infected Cell | Calu-3 Cells (Human epithelial cell line) | Cellosaurus ID | CVCL_0609 | ||||||
| Method Description | To detect the role of host protein SUCLG2 in viral infection, SUCLG2 protein knockout Calu-3 Cells were infected with SARS-COV-2 for 7 - 9 Days , and the effects on infection was detected through CRISPR-based genome-wide gene-knockout screen. | ||||||||
| Results | It is reported that knockout of SUCLG2 leads to the decreased SARS-CoV-2 RNA levels compared with control group. | ||||||||
| Full List of Virus RNA Interacting with This Protien | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| RNA Region: ORF10 (hCoV-19/Not Specified Virus Strain ) | |||||||||
| RNA Region Details |
RNA Info
Click to show the detail information of this RNA binding region
|
[2] | |||||||
| Strains Name |
hCoV-19/Not Specified Virus Strain
|
||||||||
| RNA Binding Region |
ORF10
|
||||||||
| Virus Name |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
|
||||||||
| Infection Cells | Calu-3 cells (Human Lung Cancer Cell) (CVCL_0609 ) | ||||||||
| Cell Originated Tissue | Liver | ||||||||
| Interaction Score | P-value < 0.05 | ||||||||
| Method Description | RNA pull-down assays; liquid chromatography with tandem mass spectrometry (LC-MS/MS); Wilcoxon test; MS2 affinity purification coupled with liquid chromatography-mass spectrometry (MAMS) | ||||||||
